Gout and Naftalan oil therapy: why patients with chronic gout are discovering Azerbaijan's unique treatment

Unlike many forms of arthritis, gout has a clearly identified cause: excess uric acid. When uric acid levels remain elevated for prolonged periods, monosodium urate crystals may accumulate within joints. During a gout attack, the body's immune system reacts aggressively to these crystals, producing intense inflammation and pain.

Typical symptoms include sudden severe joint pain, swelling, redness, warmth around the affected joint, restricted mobility and recurring inflammatory episodes. Without appropriate treatment, repeated attacks may eventually contribute to chronic joint damage and the development of tophi — visible deposits of urate crystals under the skin.

Modern medications such as allopurinol, febuxostat, colchicine and anti-inflammatory drugs are highly effective at lowering uric acid levels and reducing future attacks. However, many patients continue experiencing residual joint discomfort, reduced mobility, chronic stiffness, functional limitations and reduced quality of life.

This is particularly common among patients who have lived with gout for many years or who have developed chronic gouty arthropathy. For these individuals, rehabilitation therapies often become an important part of long-term management.

Naftalan oil therapy is not a replacement for uric acid-lowering medication. Instead, it is most commonly used as a complementary rehabilitation approach during periods when acute attacks are under control.

Physicians in Naftalan frequently incorporate the therapy into comprehensive treatment programs that may include medical supervision, physiotherapy, therapeutic exercise, hydrotherapy, rehabilitation procedures and Naftalan oil applications. Many patients report improvements in joint flexibility, comfort and physical function following treatment.

Dietrich M., 56, Frankfurt — Lived with gout for nearly 15 years. Although medication helped control acute attacks, persistent stiffness in his knees and ankles continued to affect daily activities. Following a 14-day Naftalan treatment program, he reported improved mobility and greater comfort while walking. At a six-month follow-up, many of these improvements remained.

David R., 51, Haifa — Experienced recurrent gout attacks affecting his feet and ankles. Between attacks, he continued to struggle with stiffness and reduced mobility. After completing a rehabilitation program that included Naftalan therapy, he reported greater flexibility and improved ability to participate in physical activity.

Mehmet K., 48, Ankara — After more than a decade of gout-related joint problems, Mehmet sought rehabilitation treatment in Naftalan. Following a 16-day program, he reported less joint discomfort, improved walking tolerance and greater confidence in daily movement.

Researchers believe that medicinal Naftalan oil contains biologically active compounds capable of influencing inflammatory processes and supporting rehabilitation outcomes. Unlike conventional petroleum products, medicinal Naftalan oil undergoes specialized processing and has been used therapeutically for generations.

Patients frequently report improvements in joint comfort, stiffness, mobility, physical function, daily activity tolerance and overall quality of life. Many specialists believe that the combination of Naftalan applications, physiotherapy, exercise and medical supervision contributes to the favorable outcomes observed in rehabilitation settings.